Workflow
Meinian Onehealth(002044)
icon
Search documents
12月11日重要公告一览
Xi Niu Cai Jing· 2025-12-11 03:04
Group 1 - Dingyang Technology has launched the SPB3000X series source load simulator, which includes three models: SPB3100X, SPB3200X, and SPB3300X, featuring high precision, low ripple noise, and fast transient response [1] - Ningbo Huaxiang plans to acquire 40% of Fengmei Power's equity from SAIC Volkswagen, with the total acquisition involving 100% equity [2] - ST Jiaotou will implement a capital reserve conversion to increase share capital, with a total of 267 million shares to be converted [3] Group 2 - Century Huatong's subsidiary Guosheng Capital holds 19.5887 million shares of Moer Thread, accounting for 4.8968% of the total share capital before the IPO [4] - Meidike intends to introduce strategic investors to its subsidiary, with an investment of 200 million yuan at a pre-investment valuation of 2.18 billion yuan [5] - Baiyun Airport reported a 12.58% year-on-year increase in passenger throughput in November, totaling 7.3228 million passengers [6] Group 3 - Shengda Resources' subsidiary Honglin Mining has received approval for a three-month extension for trial production [7] - ST Yigou's subsidiary Suning International is expected to increase net profit by approximately 992 million yuan from the sale of eight subsidiaries [8][9] - Huayi Brothers reported overdue debts totaling 52.5 million yuan, exceeding 10% of its audited net assets for 2024 [10] Group 4 - Wanshun New Materials plans to acquire 100% of Eurofoil Luxembourg for 12.3889 million euros, enhancing its aluminum foil production capabilities [11] - Wuhan Tianyuan's subsidiary plans to invest approximately 600 million yuan in two energy storage projects [12] - Maike Biological's subsidiary has received a product registration certificate for a new automatic cell morphology analyzer [13] Group 5 - CATL intends to register for the issuance of bonds not exceeding 10 billion yuan, primarily for project construction and working capital [14] - Yuntianhua plans to acquire 100% of Tianyao Chemical for 36.8858 million yuan, enhancing its fine phosphorus chemical product line [15] - Fucheng Technology's controlling shareholder has reduced its stake by 1.0429 million shares [16] Group 6 - Zhili Fang plans to reduce its stake by up to 1.2% of the company's total shares [17][18] - Qianzhao Optoelectronics' chairman intends to reduce his stake by up to 0.02% [19] - Sanmu Group's subsidiary plans to sell 75 office properties for 24.1068 million yuan [20] Group 7 - Zhuangyuan Pasture's director plans to reduce his stake by up to 3% of the company's total shares [21] - Chongqing Pharmaceutical's subsidiary has signed a licensing agreement with Pfizer, potentially earning up to 50 million USD in milestone payments [22] - Yongqing Environmental Protection's shareholder plans to reduce its stake by up to 1% [23] Group 8 - Lens Technology plans to acquire 100% of PMG International Co., Ltd., enhancing its capabilities in server cabinet business [24] - Xinbang Pharmaceutical is facing prosecution for alleged unit bribery, but its control remains unchanged [25] - Meian Health's shareholders plan to reduce their stake by up to 3% of the company's total shares [26] Group 9 - Central Plaza's subsidiary has decided to suspend operations due to ongoing operational difficulties [27] - Dawn Co. plans to acquire 80% of Ningbo Aisikai for 516 million yuan, including the transfer of related patents and technologies [28] - Kweichow Moutai will distribute over 30 billion yuan in cash dividends based on its 2025 mid-term profit distribution plan [29] Group 10 - Baiyun Airport has received approval from the CSRC for a stock issuance to specific targets [29] - Zai Sheng Technology reported that revenue from aerospace-related products will account for less than 0.5% of its total revenue in 2024 [30]
美年健康ESG:让普惠体检持续发挥价值创造
Sou Hu Cai Jing· 2025-12-11 02:57
十年深耕,美年健康以治理筑牢根基、以技术创新践行责任、以健康服务赋能公众,走出了一条兼具情怀与实效的可持续发展之路。 美年健康在ESG领域持续积极作为,涌现出诸多亮点与创新举措 投资时间网、标点财经研究员 董琳 从2015年自愿发布首份企业社会责任报告,到2025年响应深交所指南构建系统化ESG战略,美年大健康产业控股股份有限公司(下称美年健康, 002044.SZ)的ESG之路,在情怀与责任的深刻交织下,愈发平坦与光明。 在绿色技术研发和应用层面,公司实施"ALL in AI"战略,推出国内首款AI数智健管师"健康小美",为用户提供检前、检中、检后全流程服务;在绿色医 疗方面,美年健康全方位强化了体检环境的医疗安全措施,提升客户安全安心的就诊体验;在能源管理领域,美年健康依托数智化平台优化全场景无纸化 应用,将智能化减排模式融入健康服务全链条;在污染防控维度,美年健康强化污水处理全流程动态监测机制,通过智能化终端实时追踪余氯浓度、臭氧 指标等核心参数,确保排放水质始终优于国家标准。 积极履行社会责任、打造幸福企业 作为中国健康产业的重要参与者,美年健康始终秉持公益初心,深化健康产业与公益事业的融合。 自20 ...
美年健康:关于5%以上股东减持股份的预披露公告
Zheng Quan Ri Bao· 2025-12-10 14:13
证券日报网讯 12月10日晚间,美年健康发布公告称,截至本公告披露日,杭州灏月企业管理有限公司 (简称"杭州灏月")及其一致行动人杭州信投信息技术有限公司(简称"杭州信投")合计持有公司股份 392,506,268股(占公司总股本比例10.03%),其中,杭州灏月持有公司股份313,937,797股(占 公司总股本比例8.02%),杭州信投持有公司股份78,568,471股(占公司总股本比例2.01%)。杭州 灏月及杭州信投因自身资金需求,拟在减持预披露公告发布之日起15个交易日后的三个月内,以集中竞 价及大宗交易方式合计减持公司股份不超过117,427,617股,即不超过公司总股本的3%。其中,通过 集中竞价交易方式减持的公司股份不超过39,142,539股,即不超过公司总股本的1%;通过大宗交易 方式减持的公司股份不超过78,285,078股,即不超过公司总股本的2%。 (文章来源:证券日报) ...
美年健康:股东杭州灏月及一致行动人拟减持不超1.17亿股
Hua Er Jie Jian Wen· 2025-12-10 13:12
美年健康股东减持预披露公告要点解读 •减持数量:不超过1.17亿股,占总股本不超过3% •减持方式:集中竞价(不超过1%)+ 大宗交易(不 超过2%) •减持时间:公告发布15个交易日后的3个月内 •减持原因:自身资金需求 •定价方式:根据市 场价格确定 •减持股东:杭州灏月企业管理有限公司及一致行动人杭州信投信息技术有限公司 •当前持股:合计持有 3.93亿股,占总股本10.03% 重要提示 杭州灏月:3.14亿股(8.02%) • 减持股东非控股股东,本次减持不影响公司控制权 • 减持计划存在时间、数量、价格等不确定性 • 减 持符合相关法规要求 杭州信投:7,857万股(2.01%) 减持主体及持股情况 减持计划核心要素 ...
美年健康股东杭州灏月及杭州信投拟减持不超3%股份
Zhi Tong Cai Jing· 2025-12-10 12:31
美年健康(002044)(002044.SZ)公告,公司股东杭州灏月及杭州信投拟减持公司股份数量合计不超过 1.17亿股,即不超过公司总股本的3%。 ...
美年健康:杭州灏月及杭州信投拟合计减持不超3%股份
Di Yi Cai Jing· 2025-12-10 12:23
美年健康公告,股东杭州灏月及其一致行动人杭州信投因自身资金需求,拟在减持预披露公告发布之日 起15个交易日后的三个月内,以集中竞价及大宗交易方式合计减持公司股份不超过117427617股,即不 超过公司总股本的3%。 (文章来源:第一财经) ...
美年健康(002044) - 关于5%以上股东减持股份的预披露公告
2025-12-10 12:16
证券代码:002044 证券简称:美年健康 公告编号:2025-082 美年大健康产业控股股份有限公司 关于 5%以上股东减持股份的预披露公告 公司股东杭州灏月企业管理有限公司、杭州信投信息技术有限公司保证向 本公司提供的信息内容真实、准确、完整,没有虚假记载、误导性陈述或重大 遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示: 1.截至本公告披露日,杭州灏月企业管理有限公司(以下简称"杭州灏月") 及其一致行动人杭州信投信息技术有限公司(以下简称"杭州信投")合计持有美 年大健康产业控股股份有限公司(以下简称"公司")股份 392,506,268 股(占公 司总股本比例 10.03%),其中,杭州灏月持有公司股份 313,937,797 股(占公司 总股本比例 8.02%),杭州信投持有公司股份 78,568,471 股(占公司总股本比例 2.01%)。 2.杭州灏月及杭州信投因自身资金需求,拟在减持预披露公告发布之日起 15 个交易日后的三个月内,以集中竞价及大宗交易方式合计减持公司股份不超过 117,427,617 股,即不超过公司总股本的 3%。其中,通过集中竞价交 ...
12月10日深港通医疗(港币)(983036)指数跌0.28%,成份股先健科技(01302)领跌
Sou Hu Cai Jing· 2025-12-10 11:19
Core Points - The Shenzhen-Hong Kong Stock Connect Medical Index (983036) closed at 4327.65 points, down 0.28%, with a trading volume of HKD 7.682 billion and a turnover rate of 0.9% [1] - Among the index constituents, 21 stocks rose while 36 stocks fell, with Kewei Medical leading the gainers at a 4.14% increase and Xianjian Technology leading the decliners at a 9.14% decrease [1] Index Constituents Summary - The top ten constituents of the Shenzhen-Hong Kong Stock Connect Medical Index include: - Mindray Medical (sz300760) with a weight of 14.56%, latest price at HKD 198.00, and a market cap of HKD 240.063 billion, down 0.36% [1] - Yier Eye Hospital (sz300015) with a weight of 11.62%, latest price at HKD 11.23, and a market cap of HKD 104.724 billion, down 0.62% [1] - Lejin Medical (sz300003) with a weight of 4.85%, latest price at HKD 15.64, and a market cap of HKD 28.831 billion, down 0.64% [1] - Aimeike (sz300896) with a weight of 4.80%, latest price at HKD 143.25, and a market cap of HKD 43.346 billion, up 1.47% [1] - Yuyue Medical (sz002223) with a weight of 4.66%, latest price at HKD 35.68, and a market cap of HKD 35.768 billion, up 0.17% [1] - Yingke Medical (sz300677) with a weight of 3.64%, latest price at HKD 41.76, and a market cap of HKD 27.360 billion, down 0.17% [1] - Furuijia (sz300049) with a weight of 3.59%, latest price at HKD 69.33, and a market cap of HKD 18.371 billion, down 0.82% [1] - Meinian Health (sz002044) with a weight of 3.58%, latest price at HKD 5.09, and a market cap of HKD 19.924 billion, up 0.39% [1] - Sinopharm Holdings (hk01099) with a weight of 3.35%, latest price at HKD 18.15, and a market cap of HKD 56.638 billion, down 0.40% [1] - Ping An Good Doctor (hk01833) with a weight of 2.63%, latest price at HKD 12.23, and a market cap of HKD 26.434 billion, down 3.24% [1] Capital Flow Analysis - The index constituents experienced a net outflow of HKD 382 million from institutional investors, while retail investors saw a net inflow of HKD 329 million [1] - Notable individual stock capital flows include: - Meinian Health (sz002044) with a net inflow of HKD 23.6308 million from institutional investors [2] - Aimeike (sz300896) with a net inflow of HKD 5.8353 million from institutional investors [2] - Yier Eye Hospital (sz300015) with a net outflow of HKD 20.7620 million from retail investors [2]
北京+30商业领袖峰会成功举办,政企学研共绘性别平等与可持续发展新蓝图
Xin Lang Cai Jing· 2025-12-10 03:53
2025年12月5日,由联合国妇女署中国办公室主办的"北京+30"商业领袖峰会在北京圆满落幕。本次峰会恰逢《北京宣言》和《行动纲要》通过30周年、联合 国妇女署成立15周年及《赋权予妇女原则》(WEPs)发布15周年两大里程碑时刻,来自国际组织、政府部门、企业界、公益机构的各界代表齐聚一堂, 以"领导力、创新、责任与行动"为核心,共商女性赋权与包容性发展路径,凝聚全球共识与中国实践力量。 2025年12月5日,由联合国妇女署中国办公室主办的"北京+30"商业领袖峰会在北京圆满落幕。本次峰会恰逢《北京宣言》和《行动纲要》通过30周年、联合 国妇女署成立15周年及《赋权予妇女原则》(WEPs)发布15周年两大里程碑时刻,来自国际组织、政府部门、企业界、公益机构的各界代表齐聚一堂, 以"领导力、创新、责任与行动"为核心,共商女性赋权与包容性发展路径,凝聚全球共识与中国实践力量。 锚定性别平等的全球价值与中国担当 联合国妇女署中国办公室临时代办王楚乔在开幕辞中指出,《北京宣言》和《行动纲要》仍是全球促进妇女权利的核心行动蓝图,30年来全球女性劳动参与 率提升、贫困率下降,但性别差距依然严峻—全球女性仅占管理岗位30% ...
12月8日深港通医疗(港币)(983036)指数跌0.24%,成份股锦欣生殖(01951)领跌
Sou Hu Cai Jing· 2025-12-08 11:22
Core Insights - The Shenzhen-Hong Kong Stock Connect Medical Index (983036) closed at 4406.89 points, down 0.24%, with a trading volume of HKD 7.939 billion and a turnover rate of 0.88% [1] - Among the index constituents, 23 stocks rose while 34 stocks fell, with Yiyang Sunshine leading the gainers at 3.98% and Jinxin Fertility leading the decliners at 3.89% [1] Index Constituents Summary - The top ten constituents of the Shenzhen-Hong Kong Stock Connect Medical Index are as follows: - Mindray Medical (sz300760) holds a weight of 14.56%, latest price at HKD 200.05, down 1.16%, with a market cap of HKD 242.549 billion [1] - Aier Eye Hospital (sz300015) has a weight of 11.62%, latest price at HKD 11.40, up 0.89%, with a market cap of HKD 106.31 billion [1] - Lepu Medical (sz300003) has a weight of 4.85%, latest price at HKD 15.89, up 0.38%, with a market cap of HKD 29.292 billion [1] - Aimeike (sz300896) has a weight of 4.80%, latest price at HKD 142.81, down 0.11%, with a market cap of HKD 43.213 billion [1] - Yuyue Medical (sz002223) has a weight of 4.66%, latest price at HKD 35.84, down 0.83%, with a market cap of HKD 35.929 billion [1] - Yingke Medical (sz300677) has a weight of 3.64%, latest price at HKD 43.72, up 0.97%, with a market cap of HKD 28.644 billion [1] - Furuide (sz300049) has a weight of 3.59%, latest price at HKD 70.75, up 0.71%, with a market cap of HKD 18.747 billion [1] - Meinian Onehealth (sz002044) has a weight of 3.58%, latest price at HKD 5.13, down 0.58%, with a market cap of HKD 20.08 billion [1] - Sinopharm (hk01099) has a weight of 3.35%, latest price at HKD 18.51, down 0.97%, with a market cap of HKD 57.767 billion [1] - Ping An Good Doctor (hk01833) has a weight of 2.63%, latest price at HKD 13.18, up 0.21%, with a market cap of HKD 28.495 billion [1] Capital Flow Analysis - The index constituents experienced a net outflow of main funds totaling HKD 230 million, while retail investors saw a net inflow of HKD 268 million [1] - Detailed capital flow for specific stocks shows: - Furuide (sz300049) had a main fund net inflow of HKD 8.7323 million, with retail outflows of HKD 3.3726 million [2] - Aier Eye Hospital (sz300015) had a main fund net inflow of HKD 6.6536 million, with retail outflows of HKD 1.8752 million [2] - Lepu Medical (sz300003) had a main fund net inflow of HKD 3.7716 million, with retail outflows of HKD 0.7273 million [2]